• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮患者的药物滥用患病率及相关因素:一项单中心、横断面研究。

Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: A single-centre, cross-sectional study.

机构信息

Department of General Internal Medicine, Tenri Hospital, Nara, Japan.

Department of Infection Control, Graduate School of Medicine, Osaka University, Osaka, Japan.

出版信息

Mod Rheumatol. 2023 Dec 22;34(1):106-112. doi: 10.1093/mr/roac155.

DOI:10.1093/mr/roac155
PMID:36508299
Abstract

OBJECTIVES

This study aimed to clarify factors associated with polypharmacy among patients with systemic lupus erythematosus.

METHODS

This single-centre cross-sectional study was conducted by reviewing the medical records and questionnaire data of 261 systemic lupus erythematosus patients at a teaching hospital in Japan from 1 September to 30 November 2020. Polypharmacy was defined as the regular administration of five or more oral medications; excessive polypharmacy consisted of the regular use of 10 or more oral medications. This study investigated (1) the prevalence of polypharmacy and excessive polypharmacy, (2) the distribution of medication types, and (3) the factors associated with polypharmacy and excessive polypharmacy.

RESULTS

The proportions of patients who exhibited polypharmacy and excessive polypharmacy were 70% and 19%, respectively. Polypharmacy was associated with older age, long duration of systemic lupus erythematosus, high disease activity, and administration of glucocorticoids or immunosuppressive agents. Excessive polypharmacy was associated with a higher updated Charlson comorbidity index, history of visits to multiple internal medicine clinics, and presence of public assistance.

CONCLUSIONS

Polypharmacy and excessive polypharmacy in patients with systemic lupus erythematosus are related to medical aspects such as disease severity and comorbidities in addition to social aspects such as hospital visitation patterns and economic status.

摘要

目的

本研究旨在阐明与系统性红斑狼疮患者多种药物治疗相关的因素。

方法

本单中心横断面研究通过回顾 2020 年 9 月 1 日至 11 月 30 日期间在日本一家教学医院的 261 例系统性红斑狼疮患者的病历和问卷调查数据进行。多种药物治疗定义为常规使用五种或以上口服药物;过度多种药物治疗包括常规使用十种或以上口服药物。本研究调查了(1)多种药物治疗和过度多种药物治疗的患病率,(2)药物类型的分布,以及(3)与多种药物治疗和过度多种药物治疗相关的因素。

结果

出现多种药物治疗和过度多种药物治疗的患者比例分别为 70%和 19%。多种药物治疗与年龄较大、系统性红斑狼疮病程较长、疾病活动度高以及使用糖皮质激素或免疫抑制剂有关。过度多种药物治疗与更高的更新版 Charlson 合并症指数、多次就诊于多个内科诊所的病史以及享受公共援助有关。

结论

系统性红斑狼疮患者的多种药物治疗和过度多种药物治疗与疾病严重程度和合并症等医学方面以及就诊模式和经济状况等社会方面有关。

相似文献

1
Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: A single-centre, cross-sectional study.系统性红斑狼疮患者的药物滥用患病率及相关因素:一项单中心、横断面研究。
Mod Rheumatol. 2023 Dec 22;34(1):106-112. doi: 10.1093/mr/roac155.
2
Prevalence and factors associated with polypharmacy among patients with rheumatoid arthritis: a single-centre, cross-sectional study.类风湿关节炎患者中药物滥用的流行情况及相关因素:一项单中心、横断面研究。
Clin Rheumatol. 2023 Sep;42(9):2287-2295. doi: 10.1007/s10067-023-06646-0. Epub 2023 May 27.
3
Polypharmacy and Potentially Inappropriate Medication Use in Older Adults With Systemic Lupus Erythematosus.老年系统性红斑狼疮患者的多种药物治疗和潜在不适当药物使用。
Arthritis Care Res (Hoboken). 2023 Feb;75(2):356-364. doi: 10.1002/acr.24766. Epub 2022 Oct 11.
4
Latent Tuberculosis Infection and Associated Factors in Patients with Systemic Lupus Erythematosus: a Multicenter, Cross-Sectional Study.潜伏性结核感染及系统性红斑狼疮患者的相关因素:一项多中心、横断面研究。
Microbiol Spectr. 2023 Jun 15;11(3):e0084823. doi: 10.1128/spectrum.00848-23. Epub 2023 May 9.
5
Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.查尔森合并症指数与系统性红斑狼疮的器官损伤相关:来自韩国狼疮网络(KORNET)注册研究的数据。
J Rheumatol. 2017 Apr;44(4):452-458. doi: 10.3899/jrheum.160900.
6
Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study.红斑狼疮性肾炎患者高血压和血脂异常的患病及治疗情况:一项多中心横断面研究。
Lupus. 2021 Jun;30(7):1146-1153. doi: 10.1177/09612033211006790. Epub 2021 Apr 1.
7
Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort.迟发性系统性红斑狼疮:与青少年和成人发病患者相比的特征和结局-一项多中心回顾性队列研究。
Clin Rheumatol. 2020 Feb;39(2):435-442. doi: 10.1007/s10067-019-04776-y. Epub 2019 Nov 22.
8
Factors and Reasons for Non-vaccination among Patients with Systemic Lupus Erythematosus: A Single-centre, Cross-sectional Study.系统性红斑狼疮患者未接种疫苗的因素和原因:一项单中心、横断面研究。
Intern Med. 2023 Sep 1;62(17):2483-2491. doi: 10.2169/internalmedicine.1067-22. Epub 2022 Dec 28.
9
Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.泰国接受免疫抑制剂治疗的系统性红斑狼疮患者中卵巢早衰的患病率
Lupus. 2016 Apr;25(4):436-44. doi: 10.1177/0961203315617539. Epub 2015 Nov 29.
10
Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study.循环鞘脂失调与女性系统性红斑狼疮患者的疾病活动指数相关:一项横断面研究。
Lupus. 2017 Sep;26(10):1023-1033. doi: 10.1177/0961203316686707. Epub 2017 Jan 29.

引用本文的文献

1
The association between polypharmacy and disease control in rheumatoid arthritis and systemic lupus erythematosus: a cohort study.类风湿关节炎和系统性红斑狼疮中多重用药与疾病控制之间的关联:一项队列研究。
Rheumatol Int. 2025 Feb 8;45(3):44. doi: 10.1007/s00296-025-05804-8.
2
Medication-related hospitalisations in patients with SLE.系统性红斑狼疮患者与药物相关的住院情况。
Lupus Sci Med. 2025 Jan 30;12(1):e001362. doi: 10.1136/lupus-2024-001362.
3
Recipients of public assistance with advanced chronic kidney disease: insights into receiving a presentation of kidney replacement therapy options and polypharmacy from Japanese investigators with innovative network about kidney disease study.
晚期慢性肾病公共援助接受者:来自日本具有创新肾病研究网络的研究者关于肾脏替代治疗选择及多种药物治疗的介绍见解
Clin Exp Nephrol. 2025 Jan;29(1):67-74. doi: 10.1007/s10157-024-02549-9. Epub 2024 Aug 22.
4
Health Statuses of People in Poverty Receiving Public Assistance in Japan: A Scoping Review.日本接受公共援助的贫困人口的健康状况:一项范围综述。
JMA J. 2024 Jul 16;7(3):301-312. doi: 10.31662/jmaj.2024-0062. Epub 2024 Jun 28.
5
Promoting awareness of terminology related to unmet medical needs in context of rheumatic diseases in Japan: a systematic review for evaluating unmet medical needs.在日本风湿性疾病背景下促进与未满足医疗需求相关术语的认知:评估未满足医疗需求的系统评价。
Rheumatol Int. 2023 Nov;43(11):2021-2030. doi: 10.1007/s00296-023-05425-z. Epub 2023 Aug 19.
6
Prevalence and factors associated with polypharmacy among patients with rheumatoid arthritis: a single-centre, cross-sectional study.类风湿关节炎患者中药物滥用的流行情况及相关因素:一项单中心、横断面研究。
Clin Rheumatol. 2023 Sep;42(9):2287-2295. doi: 10.1007/s10067-023-06646-0. Epub 2023 May 27.